Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists-Reference-Cited by-同舟云学术

Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists

Published:2018-05-02 Issue:1 Volume:37 Page:17-26
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Molinos-Quintana A.,Trujillo-Hacha P.,Piruat J. I.,Bejarano-García J. A.,García-Guerrero E.,Pérez-Simón J. A.,Muñoz Miguel

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-018-0607-8.pdf

Reference41 articles.

1. Deschler B, Lubbert M (2006) Acute myeloid leukemia: epidemiology and etiology. Cancer 107:2099–2107

2. Hennig IM, Laissue JA, Horisberger U, Reubi JC (1995) Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer 61(6):786–792

3. Luo W, Sharif TR, Sharif M (1996) Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway. Cancer Res 56(21):4983–4991

4. Palma C (2006) Tachykinins and their receptors in human malignancies. Curr Drug Targets 7(8):1043–1052

5. Patacchini R, Lecci A, Holzer P, Maggi CA (2004) Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclature. Trends Pharmacol Sci 25(1):1–3

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumor Strategies Targeting Peptidergic Systems;Encyclopedia;2024-03-06

2. Advances in the research and application of neurokinin-1 receptor antagonists;Journal of Zhejiang University-SCIENCE B;2024-02

3. Fighting Cancer Using Selective Antagonists Targeting the Substance P/Neurokinin-1 Receptor System;Interdisciplinary Cancer Research;2024

4. The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant;International Journal of Molecular Sciences;2023-11-03

5. The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive;International Journal of Molecular Sciences;2023-10-23